Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(acetylamino)benzeneacetic Acid
2. 4-acetylaminophenylacetic Acid
3. Ms 932
4. Ms-932
1. 18699-02-0
2. 2-(4-acetamidophenyl)acetic Acid
3. 4-acetylaminophenylacetic Acid
4. 4-acetamidophenylacetic Acid
5. Benzeneacetic Acid, 4-(acetylamino)-
6. Orcl
7. [4-(acetylamino)phenyl]acetic Acid
8. (p-acetamidophenyl)acetic Acid
9. 4-(acetylamino)benzeneacetic Acid
10. Mirabegron (m9)
11. Ms-932
12. Nsc-170317
13. Ym-340790
14. Hw5b6351rz
15. Mfcd00196165
16. 4-acetylaminophenylacetic Acid;ms-932
17. Ncgc00160450-01
18. Dsstox_cid_20
19. Mover
20. Dsstox_rid_75323
21. Dsstox_gsid_20020
22. Actarit [inn:jan]
23. Actaritum
24. Actaritum [inn-latin]
25. Smr000466341
26. Cas-18699-02-0
27. Ccris 3777
28. 4-n-acetylaminophenylacetic Acid
29. Benzeneaceticacid, 4-(acetylamino)-
30. Einecs 242-511-3
31. Ms 932
32. Nsc 170317
33. Brn 1640927
34. Unii-hw5b6351rz
35. Actrarit
36. Actarit-[d4]
37. Orcl (tn)
38. Actarit (jan/inn)
39. Actarit [inn]
40. Actarit [jan]
41. Actarit [mi]
42. Actarit [mart.]
43. Actarit [who-dd]
44. Schembl78305
45. 2-14-00-00281 (beilstein Handbook Reference)
46. Mls000759453
47. Mls000881203
48. Mls001423954
49. (4-acetamido-phenyl)acetic Acid
50. Chembl1885632
51. Dtxsid0020020
52. Chebi:31173
53. (4-acetamino-phenyl)-acetic Acid
54. Hms2051c06
55. Hms2235a24
56. Hms3393c06
57. Hms3715f18
58. Acetic Acid, (p-acetamidophenyl)-
59. Mirabegron M9 (ym-340790)
60. (4-acetylamino-phenyl)-acetic Acid
61. Bcp12510
62. Cs-m1344
63. Zinc6165883
64. Tox21_111820
65. Tox21_301197
66. Ab6003
67. Nsc170317
68. S5039
69. Akos000104755
70. Tox21_111820_1
71. Ac-1285
72. Ccg-100840
73. Ks-5131
74. Nc00090
75. Ncgc00160450-02
76. Ncgc00160450-03
77. Ncgc00255094-01
78. Am803419
79. Hy-76938
80. Db-044623
81. Ft-0630454
82. En300-13165
83. Vu0254342-5
84. D01395
85. Ab00172855-09
86. Ab00172855-11
87. Ab00172855_13
88. 699a020
89. A813101
90. A935860
91. J-012024
92. Q4676759
93. Z90122510
94. F9995-0122
| Molecular Weight | 193.20 g/mol |
|---|---|
| Molecular Formula | C10H11NO3 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 193.07389321 g/mol |
| Monoisotopic Mass | 193.07389321 g/mol |
| Topological Polar Surface Area | 66.4 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 219 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antirheumatic Agents
Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)
ABOUT THIS PAGE
A Actarit manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Actarit, including repackagers and relabelers. The FDA regulates Actarit manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Actarit API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Actarit supplier is an individual or a company that provides Actarit active pharmaceutical ingredient (API) or Actarit finished formulations upon request. The Actarit suppliers may include Actarit API manufacturers, exporters, distributors and traders.
click here to find a list of Actarit suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Actarit Drug Master File in Japan (Actarit JDMF) empowers Actarit API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Actarit JDMF during the approval evaluation for pharmaceutical products. At the time of Actarit JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Actarit suppliers with JDMF on PharmaCompass.
Actarit Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Actarit GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Actarit GMP manufacturer or Actarit GMP API supplier for your needs.
A Actarit CoA (Certificate of Analysis) is a formal document that attests to Actarit's compliance with Actarit specifications and serves as a tool for batch-level quality control.
Actarit CoA mostly includes findings from lab analyses of a specific batch. For each Actarit CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Actarit may be tested according to a variety of international standards, such as European Pharmacopoeia (Actarit EP), Actarit JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Actarit USP).
LOOKING FOR A SUPPLIER?
